Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress.
The 10 matches
- [1] § 4. Materials and Methods › 4.5. Gait Parameter Assessment › 4.5.3. Calculation of Gait Parameters ↔ Gait/gait_data_analysis_scripts/main.R, lines 43–95 · score 0.84 · gait cycle, phase durations, Body length, Stride length, duty factor, segments
- [2] § 4. Materials and Methods › 4.5. Gait Parameter Assessment › 4.5.2. Markerless Pose Estimation Using Lightning Pose ↔ Gait/gait_data_analysis_scripts/config.R, lines 23–40 · score 0.81 · left hind, right hind, left front, right front, cutoff, paw
- [3] § 4. Materials and Methods › 4.8. Statistical Analysis ↔ Open_Field/Chron_MBG_OF_analysis.Rmd, lines 262–300 · score 0.79 · glmmTMB, baseline distance, lme4, mouse ID, Gamma, fitted
- [4] § 4. Materials and Methods › 4.8. Statistical Analysis ↔ Enzyme_activity/enzyme_MBG_14_day.Rmd, lines 93–176 · score 0.71 · Log2 fold change, enzyme activity, aCSF, heatmap, MBG
- [5] § 2. Results › 2.1. Impact of 14-Day ICV Administration of 1.5 μL of 100 μM Marinobufagenin on Locomotor Activity and Anxiety-like Behavior in Mice During a 20-min Open Field Test ↔ Open_Field/Chron_MBG_OF_analysis.Rmd, lines 262–300 · score 0.70 · post hoc, open field, Baseline center, aCSF, predicted, GLMM
- [6] § 4. Materials and Methods › 4.7. Determination of Enzyme Activity and MDA Content › 4.7.2. Catalase Activity Assay ↔ Enzyme_activity/enzyme_MBG_14_day.Rmd, lines 224–271 · score 0.66 · CAT activity, mg protein, enzyme activity, min
- [7] § 2. Results › 2.2. Impact of 14-Day ICV Administration of 1.5 μL of 100 μM Marinobufagenin on Gait ↔ Gait/gait_data_analysis_scripts/main.R, lines 43–95 · score 0.65 · body length, linear mixed, post hoc, stride length, duty factor, metrics
- [8] § 2. Results › 2.3. Effects of 14-Day ICV Administration of 1.5 μL of 100 μM Marinobufagenin on Monoamine and Metabolite Concentrations in Mouse Brain Tissue ↔ Monoamines_HPLC/HPLC_analysis_scripts/config.R, lines 48–119 · score 0.58 · MT, cerebellum, norepinephrine, HIAA, hippocampus, serotonin
- [9] § 4. Materials and Methods › 4.8. Statistical Analysis ↔ Monoamines_HPLC/HPLC_analysis_scripts/config.R, lines 1–46 · score 0.58 · Shapiro Wilk, Wilcoxon, HPLC, compound, heatmap, treatment
- [10] § 4. Materials and Methods › 4.6. Monoamine Level Evaluation Using High-Performance Liquid Chromatography with Electrochemical Detection ↔ Monoamines_HPLC/HPLC_analysis_scripts/config.R, lines 48–119 · score 0.57 · MT, Norepinephrine, cerebellum, HIAA, Serotonin, hippocampus
Paper
Loaded from Europe PMC by your browser, not stored by OSCR: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
R · 119 lines · 4.7 KB · no license · 3 matches
- # ==============================================================================
- # HPLC ANALYSIS PIPELINE: CONFIGURATION & DOCUMENTATION
- # ==============================================================================
- #
- # OVERVIEW:
- # This pipeline automates the processing of HPLC monoamine data by merging
- # analytical results and experimental metadata.
- #
- # ------------------------------------------------------------------------------
- # INPUT FILE ARCHITECTURE
- # ------------------------------------------------------------------------------
- # All analysis is linked via the 'sample_ID' column.
- #
- # 1. HPLC DATA (.csv)
- # Naming: YYYY_MM_DD_[EXPERIMENT]_[BATCH]_[INITIALS]_HPLC.csv
- # Columns used:
- # - [sample_ID]: Primary Join Key.
- # - [compound]: Neurotransmitter name (DA, 5-HT, etc.).
- # - [conc_pmol_L]: Analytical measurement (Not detected values set to "-").
- # - [source_file, sample_num, chrom_ID, retention_time_min, area_mV_s, height_mV]
- #
- # 2. TISSUE ACQUISITION LOG (.csv)
- # Naming: YYYY_MM_DD_[EXPERIMENT]_[BATCH]_[INITIALS]_tissue_acquisition_log.csv
- # Columns used:
- # - [sample_ID]: Join Key.
- # - [mouse_ID]: Unique animal identifier (for tracking individuals).
- # - [VAR_...]: Any column starting with "VAR_" (e.g., VAR_Treatment, VAR_Group).
- # - [sample_mass_mg, acquisition_date, acquisition_ID]
- #
- # ------------------------------------------------------------------------------
- # PIPELINE STAGES
- # ------------------------------------------------------------------------------
- # STAGE 01: Data Prep. Performs a Double-Join. Calculates ratios (e.g., DOPAC/DA).
- # STAGE 02: Stats. Checks normality (Shapiro-Wilk). Chooses T-test/Wilcoxon
- # (for 1 variable) or ANOVA/Kruskal-Wallis (for multiple variables).
- # STAGE 03: Plots. Generates Boxplots in localized folders (EN/RU).
- # STAGE 04: Heatmap. Generates linear intensity heatmaps showing % change vs.
- # control with p-values and significance stars printed in cells.
- #
- # ==============================================================================
- # CONFIGURATION
- # ==============================================================================
- exp_name <- "Chron_MBG_2W"
- show_sample_labels <- FALSE # Set to FALSE to hide IDs on plots
- # --- Config for dynamic scaling
- plot_unit_width <- 4 # Inches per plot column
- plot_unit_height <- 4.5 # Inches per plot row
- plots_per_row <- 3 # Number of columns in the grid
- # --- DIRECTORIES ---
- dir_hplc_raw <- "/mnt/lab_vault/projects/Project_Chron_MBG_2W/02_Raw_Data/Phase_03_Assays/01_HPLC/"
- dir_metadata <- "/mnt/lab_vault/projects/Project_Chron_MBG_2W/02_Raw_Data/Phase_03_Assays/01_HPLC/"
- dir_output <- "./01_Output"
- dir_logs <- "./00_Logs"
- # --- SETTINGS ---
- var_prefix <- "VAR_"
- exclude_compounds <- c("DHBA")
- # Define the lookup table for clean plot titles
- compound_names <- list(
- "NE" = "Norepinephrine",
- "DA" = "Dopamine",
- "5-HT" = "Serotonin",
- "DOPAC" = "DOPAC",
- "HVA" = "HVA",
- "HIAA" = "5-HIAA",
- "3-MT" = "3-MT",
- "DHBA" = "DHBA (Internal Standard)"
- )
- compound_names[["HIAA/5-HT"]] <- "5-HIAA / 5-HT Ratio"
- compound_names[["HVA/DA"]] = "HVA / DA Ratio"
- compound_names[["DOPAC/DA"]] = "DOPAC / DA Ratio"
- structure_map <- list(
- "EN" = c("Sr" = "Striatum", "Co" = "PFC", "H" = "Hippocampus", "T" = "Thalamus", "St" = "Brain Stem", "Ce" = "Cerebellum"),
- "RU" = c("Sr" = "Стриатум", "Co" = "ПФК", "H" = "Гиппокамп", "T" = "Таламус", "St" = "Ствол Мозга", "Ce" = "Мозжечок")
- )
- y_labels <- list(
- "EN" = c("conc" = "pmol/mg tissue", "ratio" = "Ratio"),
- "RU" = c("conc" = "пмоль/мг ткани", "ratio" = "Отношение")
- )
- plot_order <- c(
- "DA", "HVA", "HVA_DA_ratio",
- "DOPAC", "DOPAC_DA_ratio",
- "3-MT", "3-MT_DA_ratio",
- "NE", "NE_DA_ratio",
- "5-HT", "HIAA", "HIAA_5-HT_ratio"
- )
- compound_names_en <- list(
- "DA"="Dopamine", "HVA"="HVA", "HVA_DA_ratio"="HVA/DA",
- "DOPAC"="DOPAC", "DOPAC_DA_ratio"="DOPAC/DA", "3-MT"="3-MT",
- "3-MT_DA_ratio"="3-MT/DA", "NE"="Norepinephrine", "NE_DA_ratio"="NE/DA",
- "5-HT"="Serotonin", "HIAA"="5-HIAA", "HIAA_5-HT_ratio"="5-HIAA/5-HT"
- )
- compound_names_ru <- list(
- "DA"="Дофамин", "HVA"="ГВК", "HVA_DA_ratio"="ГВК/ДА",
- "DOPAC"="ДОФУК", "DOPAC_DA_ratio"="ДОФУК/ДА", "3-MT"="3-МТ",
- "3-MT_DA_ratio"="3-МТ/ДА", "NE"="Норадреналин", "NE_DA_ratio"="НА/ДА",
- "5-HT"="Серотонин", "HIAA"="5-ГИУК", "HIAA_5-HT_ratio"="5-ГИУК/5-HT"
- )
- struct_seq <- c("Sr", "Co", "H", "T", "St", "Ce")
- compound_seq <- c(
- "DA", "HVA", "HVA_DA_ratio",
- "DOPAC", "DOPAC_DA_ratio",
- "3-MT", "3-MT_DA_ratio",
- "NE", "NE_DA_ratio",
- "5-HT", "HIAA", "HIAA_5-HT_ratio"
- )
config.R, no license · at the source
Overview
- Institute of Translational Biomedicine, St. Petersburg State University, Universitetskaya Nab. 7/9, 199034 St. Petersburg, Russia; (A.O.L.); (A.D.I.); (A.B.V.)
- Biological Department, St. Petersburg State University, 199034 St. Petersburg, Russia
- Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia; (D.A.A.); (O.I.K.)
- Johns Hopkins University, Baltimore, MD 21218, USA
Abstract
Cardiotonic steroids (CTS) can modulate central nervous system function through their interaction with the Na+,K+-ATPase, affecting dopaminergic transmission. While the CTS ouabain is known to induce mania-like behavior and oxidative damage, the effects of other CTS are less clear. This study examined the effects of 14-day intracerebroventricular administration of 1.5 μL 100 μM marinobufagenin (MBG) on locomotion, gait, monoamine metabolism, and oxidative stress markers (MDA, SOD, catalase, MAO-B) in C57BL/
Reproduced under the paper's license (CC BY), from the paper cited above.
Repository
Its files are read in the Code ↔ Paper reader above, with 10 matches between paragraphs and lines of code.
OSF 4rtsg
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
- 27 September 2026: the link answers (HTTP 200)
7 files
- Enzyme_activity/
enzyme_MBG_14_day.Rmd , R, 396 lines, 2 matches - Gait/
gait_data_analysis_scrip , R, 40 lines, 1 matchts/ config.R - Gait/
gait_data_analysis_scrip , R, 95 lines, 2 matchests/ main.R - Gait/
gait_video_preprocessing , Python, 167 lines_script/ cropper_v2.py - Monoamines_HPLC/
HPLC_analysis_scripts/ , R, 119 lines, 3 matchesconfig.R - Monoamines_HPLC/
HPLC_analysis_scripts/ , R, 61 linesmain.R - Open_Field/
Chron_MBG_OF_analysis.Rm , R, 762 lines, 2 matchesd
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 7 scripts, each with its path and the digest of its content;
- 10 matches between paragraphs of the paper and lines of the code (method lexical-v1);
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data Availability Statement
Data and analysis scripts used in this study are available in an OSF repository—https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 9 keywords, 12 MeSH terms, 2 funders, 80 references.
Cite
This paper
Kazanskaya, R. B., Lobaskova, A. O., Iushina, A. D., Abaimov, D. A., Kulikova, O. I., Volnova, A. B., Tsytsarev, V., & Lopachev, A. V. (2026). Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress. International journal of molecular sciences, 27(13), 5713. https://
BibTeX
@article{kazanskaya2026c
author = {Kazanskaya, Rogneda B. and Lobaskova, Arina O. and Iushina, Anna D. and Abaimov, Denis A. and Kulikova, Olga I. and Volnova, Anna B. and Tsytsarev, Vassiliy and Lopachev, Alexander V.},
title = {{Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress}},
journal = {International journal of molecular sciences},
year = {2026},
month = jun,
volume = {27},
number = {13},
pages = {5713},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {1422-0067},
doi = {10.3390/
url = {https://
pmid = {42449986},
pmcid = {PMC13361798}
}
RIS
TY - JOUR
AU - Kazanskaya, Rogneda B.
AU - Lobaskova, Arina O.
AU - Iushina, Anna D.
AU - Abaimov, Denis A.
AU - Kulikova, Olga I.
AU - Volnova, Anna B.
AU - Tsytsarev, Vassiliy
AU - Lopachev, Alexander V.
TI - Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress
T2 - International journal of molecular sciences
J2 - Int J Mol Sci
PY - 2026
DA - 2026/
VL - 27
IS - 13
SP - 5713
SN - 1422-0067
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3390/
"type": "article-journal",
"title": "Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress",
"container-title": "International journal of molecular sciences",
"author": [
{
"family": "Kazanskaya",
"given": "Rogneda B."
},
{
"family": "Lobaskova",
"given": "Arina O."
},
{
"family": "Iushina",
"given": "Anna D."
},
{
"family": "Abaimov",
"given": "Denis A."
},
{
"family": "Kulikova",
"given": "Olga I."
},
{
"family": "Volnova",
"given": "Anna B."
},
{
"family": "Tsytsarev",
"given": "Vassiliy"
},
{
"family": "Lopachev",
"given": "Alexander V."
}
],
"container-title-short":
"volume": "27",
"issue": "13",
"page": "5713",
"DOI": "10.3390/
"PMID": "42449986",
"PMCID": "PMC13361798",
"ISSN": "1422-0067",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
24
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1093/bioinformatics/btag592 [code]
- Network-based stratification of allele-specific expression reveals patient subgroups in Huntington's disease.Journal: Bioinformatics (Oxford, England)In common: rstatix, car, broom, 9 other tools, other condition
- [2] doi:10.1038/s41467-026-73865-9 [code]
- Histamine shapes the neurocomputational dynamics of human learning.Journal: Nature communicationsIn common: rstatix, car, broom, 9 other tools
- [3] doi:10.1016/j.celrep.2026.117646 [code]
- Medial entorhinal-hippocampal desynchronization parallels the emergence of memory impairment in a mouse model of Alzheimer's disease pathology.Journal: Cell reportsIn common: rstatix, car, broom, 8 other tools, mouse
- [4] doi:10.1016/j.celrep.2026.117505 [code]
- Impaired spatial coding and neuronal hyperactivity in the medial entorhinal cortex of aged APP knock-in mice.Journal: Cell reportsIn common: glmmTMB, car, broom, 7 other tools, mouse
- [5] doi:10.1126/sciadv.aeb8106 [code]
- A thyroid hormone-mediated opsin switch initiates metamorphosis in a proto-vertebrate.Journal: Science advancesIn common: rstatix, car, broom, 7 other tools
- [6] doi:10.1016/j.xcrm.2026.102766 [code]
- A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.Journal: Cell reports. MedicineIn common: car, lmerTest, lme4, 8 other tools, other condition, cellular / molecular
- [7] doi:10.1126/sciadv.aec9291 [code]
- Computational mechanisms of perception in autism revealed using games inspired by rodent operant tasks.Journal: Science advancesIn common: rstatix, car, broom, 7 other tools
- [8] doi:10.1073/pnas.2603114123 [code]
- The human hippocampus can pattern separate memories by meaning.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: rstatix, broom, emmeans, 8 other tools
- [9] doi:10.1038/s41398-026-04010-9 [code]
- Bullying victimization and brain development: a longitudinal structural magnetic resonance imaging study from adolescence to early adulthood.Journal: Translational psychiatryIn common: rstatix, broom, emmeans, 7 other tools
- [10] doi:10.1073/pnas.2606871123 [code]
- Oxytocin modulates the neurocomputational mechanisms engaged in learning rank relationships in social networks.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: car, broom, emmeans, 7 other tools
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 7 scripts, and 10 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:88885186074da969…
Add the badge to its README
The badge links the code to this page. Copy one of these into the README of the paper's code: only you decide where it goes, and nothing is changed for you.
Markdown
[.
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
